Zobrazeno 1 - 10
of 102
pro vyhledávání: '"Joel R. Saper"'
Autor:
Joel R Saper
Publikováno v:
Revista Cubana de Medicina, Vol 40, Iss 1, Pp 50-74 (2001)
Externí odkaz:
https://doaj.org/article/9011926009c8458d8c03f5f7417e7075
Autor:
Stewart J. Tepper, David Kudrow, Eric Liebler, Joel R. Saper, Emily Rubenstein Engel, Candace McClure, Anne H. Calhoun, Laszlo L. Mechtler, Stephen D. Silberstein
Publikováno v:
Headache: The Journal of Head and Face Pain. 56:1317-1332
Objective To evaluate non-invasive vagus nerve stimulation (nVNS) as an acute cluster headache (CH) treatment. Background Many patients with CH experience excruciating attacks at a frequency that is not sufficiently addressed by current symptomatic t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f43ec11c0a43fcb5319c8b291eb6c421
https://doi.org/10.1111/head.12896
https://doi.org/10.1111/head.12896
Autor:
Joel R. Saper, Stephen D. Silberstein, Anne H. Calhoun, Roger Cady, Kristy A. Simmons, Eric Liebler, Stefanie Dorlas, Chris Mullin, Peter J. Goadsby, Brian M. Grosberg, Richard B. Lipton
Publikováno v:
Neurology. 87:529-538
Objective: To evaluate the feasibility, safety, and tolerability of noninvasive vagus nerve stimulation (nVNS) for the prevention of chronic migraine (CM) attacks. Methods: In this first prospective, multicenter, double-blind, sham-controlled pilot s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ab71ea9034ae25df35248284d37c853
https://doi.org/10.1212/wnl.0000000000002918
https://doi.org/10.1212/wnl.0000000000002918
Autor:
Robert D. Black, Deborah K. Attix, David T. Wilkinson, Dianne L. Scott, Mohamed Sakel, Daniel T. Laskowitz, Kathryn P. Poynter, Martin D. Slade, Kristen K. Ade, Lanty L. Smith, Maragatha Kuchibhatla, Lesco L. Rogers, Marshall C. Freeman, Anne H. Calhoun, Joel R. Saper, Michael E. Hoffer
Publikováno v:
Headache. 57(7)
Objective: To evaluate the safety and efficacy of a novel solid-state, caloric vestibular stimulation (CVS) device to provide adjuvant therapy for the prevention of episodic migraine in adult migraineurs. Background: Migraine causes significant disab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b67c47c158198fd1698f0bff961917b0
https://pubmed.ncbi.nlm.nih.gov/28656612
https://pubmed.ncbi.nlm.nih.gov/28656612
Autor:
Arnaldo Neves Da Silva, Joel R. Saper
Publikováno v:
CNS Drugs. 27:867-877
Medication overuse headache (MOH) is a daily, or almost daily, headache form that arises from overuse of one or more classes of migraine-abortive or analgesic medication. The main classes of drugs that cause MOH are opioids, butalbital-containing mix
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1002eebb575d75b2d53aac77d5d211b
https://doi.org/10.1007/s40263-013-0081-y
https://doi.org/10.1007/s40263-013-0081-y
Autor:
Joel R. Saper, Randolph W. Evans
Publikováno v:
Headache: The Journal of Head and Face Pain. 53:378-381
This is a 40-year-old woman with an 18-yearhistory of migraine without aura that has beenchronic for 6 years. She has failed or been intolerantto numerous preventive medications, including topi-ramate and onabotulinum toxin even though she doesnot ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bef5fcf2565dbf1e2caba2fde4f1d26
https://doi.org/10.1111/head.12033
https://doi.org/10.1111/head.12033
Autor:
Joel R, Saper, Yosselson, Shimona
Publikováno v:
Postgraduate medicine. 57(4)
When intracranial hypertension is minimal to moderate in degree and insidious in onset, it may be asymptomatic. The clinical situation and the pathologic process responsible for the elevated pressure are the guides to selection of therapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b8050d7d5cd511d0c3f998c910698e3a
https://pubmed.ncbi.nlm.nih.gov/27410185
https://pubmed.ncbi.nlm.nih.gov/27410185
Autor:
Stephen D. Silberstein, Andrew Charles, Sheena K. Aurora, David W. Dodick, Peter J. Goadsby, Jakob Møller Hansen, Joel R. Saper, Richard B. Lipton
Publikováno v:
The Journal of Headache and Pain
Objectives: Migraine aura is commonly considered to be a distinct phase of a migraine attack that precedes headache. The objective of the study was to examine a large number of prospectively recorded attacks of migraine with aura and determine the ti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a9e88afdb869211ae07a6044f002c12
https://doi.org/10.1212/wnl.0b013e3182749eed
https://doi.org/10.1212/wnl.0b013e3182749eed
Autor:
Stephen D. Silberstein, Joel R. Saper, James Kost, Samar Froman, Tony W. Ho, Heather Leibensperger, Andrew P. Ho, Christopher Lines, Messoud Ashina, Carl Dahlöf
Publikováno v:
Cephalalgia. 30:1443-1457
Methods: This study evaluated the calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant (tablet formulation) for treatment of a migraine attack and across four attacks. Adults with migraine were randomized, double-blind, to telcagepa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b586c5d3343214db7cd410f05762dd43
https://doi.org/10.1177/0333102410370878
https://doi.org/10.1177/0333102410370878
Autor:
Maureen Moriarty, Robert L. Hamel, Mark J. Stillman, Alvin E. Lake, Ninan T. Mathew, John F. Rothrock, Joel R. Saper, Gretchen E. Tietjen, Philip A. Bain
Publikováno v:
Headache: The Journal of Head and Face Pain. 50:1175-1193
Objectives.—To provide a guide to the use and limitations of continuous opioid therapy (COT, or daily scheduled opioids) for refractory daily headache, based on the best available evidence and expert clinical experience. Background.—There has bee
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a29e97619df73d0c692fb324f0584093
https://doi.org/10.1111/j.1526-4610.2010.01733.x
https://doi.org/10.1111/j.1526-4610.2010.01733.x